O slideshow foi denunciado.

Acute Bacterial Skin and Skin-Structure Infection-ABSSSI

1

Compartilhar

Próximos SlideShares
Hepatocellular Carcinoma (HCC)
Hepatocellular Carcinoma (HCC)
Carregando em…3
×
1 de 10
1 de 10

Acute Bacterial Skin and Skin-Structure Infection-ABSSSI

1

Compartilhar

Baixar para ler offline

DelveInsight’s ABSSSI market report gives a thorough understanding of Acute Bacterial Skin and Skin-Structure Infection. It provides ABSSSI treatment algorithms and ABSSSI treatment guidelines in the US, Europe, and Japan. The ABSSSI market outlook of the report helps to build the detailed comprehension of the historical, current and forecasted trend of the ABSSSI market by analysing the impact of current therapies on the market, unmet needs, ABSSSI market drivers and ABSSSI market barriers and demand of better technology.
For more information on ABSSSI market, click here: <a href="https://www.delveinsight.com/report-store/acute-bacterial-skin-and-skin-structure-infection-absssi-market-insights-epidemiology-and-market-forecast">ABSSSI Market</a>

DelveInsight’s ABSSSI market report gives a thorough understanding of Acute Bacterial Skin and Skin-Structure Infection. It provides ABSSSI treatment algorithms and ABSSSI treatment guidelines in the US, Europe, and Japan. The ABSSSI market outlook of the report helps to build the detailed comprehension of the historical, current and forecasted trend of the ABSSSI market by analysing the impact of current therapies on the market, unmet needs, ABSSSI market drivers and ABSSSI market barriers and demand of better technology.
For more information on ABSSSI market, click here: <a href="https://www.delveinsight.com/report-store/acute-bacterial-skin-and-skin-structure-infection-absssi-market-insights-epidemiology-and-market-forecast">ABSSSI Market</a>

Mais Conteúdo rRelacionado

Acute Bacterial Skin and Skin-Structure Infection-ABSSSI

  1. 1. Acute Bacterial Skin and Skin Structure Infections
  2. 2. 05 04 03 02 01 Despite recent ABSSSI antibiotic launches, unmet needs still exist for an oral anti-MRSA agent. ABSSSI consists of the most frequently diagnosed skin infections worldwide. The ABSSSI symptoms observed are extensive cellulitis, wound infection, major cutaneous abscesses, and burn infections. ABSSSI types can be community-acquired or hospital-acquired, and the predisposing factors include trauma, chronic cutaneous lesions etc. ABSSSI is defined as a bacterial infection of Skin with a lesion size area of ≥75 cm2. DelveInsight © 2019 | All rights reserved Acute Bacterial Skin and Skin Structure Infections (ABSSSI)
  3. 3. DelveInsight © 2019 | All rights reserved ABSSSI Epidemiology • In United States, more than 15 million bacterial skin and skin structure infections occur. • ABSSSI total 7MM* Incident cases in 2017 were 7,259,777, out of which ABSSSI highest Incident cases were seen in the United States. • There were 1,942,229 male patients and 1,406,442 female cases suffering from ABSSSI in 2017 in the United States. *7MM:- Unites States; EU 5 (Germany, France, Spain, Italy, United Kingdom); Japan.
  4. 4. The ABSSSI therapeutic approaches favored in treating skin infections include adjunctive therapies, early and appropriate empiric antibiotic therapy, wound culture with susceptibility testing and surgical drainage and debridement. A large number of upcoming pipeline drugs, is expected to create a lucrative environment for growth of ABSSSI treatment market. Oral and intravenous options for ABSSSI treatment with activity against MRSA include several long-standing therapies, such as clindamycin, doxycycline etc. ABSSSI treatment includes an antimicrobial therapy, surgical drainage, and antibiotic therapy. ABSSSI Treatment DelveInsight © 2019 | All rights reserved
  5. 5. Marketed Drugs 01 02 04 03 Drug- Orbactiv Company- The Medicines Company Drug- Sivextro Company- Cubist Pharmaceutical Drug- Nuzyra Company- Paratek Pharmaceutical Drug- Baxdela Company- Melinta DelveInsight © 2019 | All rights reserved
  6. 6. DelveInsight © 2019 | All rights reserved For complete information on Acute Bacterial Skin and Skin-Structure Infection (ABSSSI) -Market Insights, Epidemiology &Market Forecast-2028 please click the link below CLICK HERE OR Write Us At info@delveinsight.com Complete Information
  7. 7. About DelveInsight is a premier Business Consulting and Market Research firm focused exclusively on the life science segment. With a wide array of smart end-to-end solutions, the firm helps the global Pharmaceutical and Bio-Tech companies formulate prudent business decisions for improving their performances to stay ahead of the competitors. Mission To provide “insights across the value chain” and helping the organization to take a prudent business decision through the use and analysis of actionable market intelligence. The mission also is to provide the most effective result and efficient service with utmost client care for maintaining a long-term relationship with them. Vision To be the most trusted market research & business consulting firm in the world; and to continue enable the Pharma & Bio-Tech companies to achieve their goals with the best strategic insight and competitive solution. The vision also is inclusive of becoming a one-stop solution provider for the entire gamut of drug development process. 1 2 3 DelveInsight © 2019 | All rights reserved About DelveInsight
  8. 8. Opportunity Assessment5 Report Store6 Competitive Analysis7 PharmDelve8 Forecasting 1 Pipeline 2 Consulting 3 Market Intelligence 4 DelveInsight © 2019 | All rights reserved Service Offerings by DelveInsight
  9. 9. DelveInsight © 2018 | All rights reserved Contact Us info@delveinsight.com +91-11-4568 9769 www.delveinsight.com blog/delveInsight/ twitter/delveInsight LinkedIn/delveInsight

×